ADAMTS9‐AS2 was one of the lncRNAs consistently downregulated in patient samples, and experimental evidence proved promoter methylation as major cause of ADAMTS9‐AS2 downregulation in breast cancer. This evidence concerns the gene ADAMTS9 and breast carcinoma.